Invectys focuses on the development of innovative anti-cancer therapeutic approaches in immunotherapy. It is backed by French and international private investors…
Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers. …
Invectys’ Scientific and Clinical Board is composed of globally recognized top specialists and key opinion leaders: Professor Maurizio Zanetti _ Senate Emeritus,…
Invectys is led by a team of experienced industry professionals, combining vision, scientific knowledge and management skills. Pierre Langlade Demoyen, Co-founder…
